Connect with us

Health/medicine

What's 'cancer cachexia' syndrome, a disease behind most patients' death?

Published

on

What's 'cancer cachexia' syndrome, a disease behind most patients' death?

New Delhi, July 8 (IANS) When tumours in cancer patients elevate levels of an immune system molecule called Interleukin-6 (IL-6), it can cause severe brain dysfunction, which leads to a lethal wasting disease called ‘cachexia’ in about 50 to 80 per cent of cancer patients, a new study said on Monday.

As per US-based Cold Spring Harbor Laboratory’s (CSHL) Professor Bo Li, “It’s a very severe syndrome”.

“Most people with cancer die of ‘cachexia’ instead of cancer. And once the patient enters this stage, there’s no way to go back because essentially there’s no treatment,” he said in a study published in the journal Nature Communications.

Li and other researchers in the team found that blocking ‘IL-6’ from binding to neurons in a part of the brain called the area postrema (AP) prevents cachexia in mice.

As a result, the mice live longer with healthier brain function.

“Future drugs targeting these neurons could help make cancer cachexia a treatable disease,” the researchers suggested.

ALSO READ:  Need to educate people on kidney damage due to antibiotic misuse: Nephrologists

In healthy patients, ‘IL-6’ plays a vital role in natural immune response. The molecules circulate throughout the body. When they encounter a possible threat, they alert the brain to coordinate a response.

According to the researchers, cancer disrupts this process as too much IL-6 gets produced, and it begins binding to AP neurons in the brain.

“That leads to several consequences. One is animals and humans alike will stop eating. Another is to engage this response that leads to the wasting syndrome,” Li said.

The team took a two-pronged approach to keeping elevated IL-6 out of the brain in mice. Their first strategy neutralised IL-6 with custom antibodies. The second used CRISPR to reduce the levels of IL-6 receptors in AP neurons. Both tactics produced the same results — the mice started eating again, stopped losing weight, and lived longer, the study noted.

“The brain is so powerful in regulating the peripheral system. Simply changing a small number of neurons in the brain has a profound effect on whole-body physiology. I knew there was an interaction between tumours and brain function, but not to this extent,” said Li.

ALSO READ:  CSIR's project to map cardio-metabolic diseases in India completes 1st phase

–IANS

shs/vd

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health/medicine

Unicef seeks $16.5 mn for mpox response in Africa

Published

on

By

Unicef seeks .5 mn for mpox response in Africa

Unicef seeks $16.5 mn for mpox response in Africa

Nairobi, Aug 22 (IANS) The United Nations Children’s Fund (Unicef) on Thursday appealed for $16.5 million to scale up mpox response in east and southern Africa.

UNICEF Regional Director for Eastern and Southern Africa, Etleva Kadilli, said in a statement issued in Nairobi, the capital of Kenya, that the new strain of mpox is a serious threat to vulnerable children and families, Xinhua news agency reported.

Children and vulnerable communities are on the verge of an expanding outbreak of mpox in the region as 200 confirmed cases have been detected across Burundi, Rwanda, Uganda, Kenya, and South Africa, the statement said.

“Aside from immediate lifesaving response, risk communication efforts and cross-border collaboration, investments in overall health system strengthening, continuity of essential services and targeted focus on programs that support overall child well-being must be prioritised,” Kadilli said.

The UN children’s agency warned concerns are rising over new public health emergencies as communities grapple with other ongoing crises. It said the new variant of the mpox virus (clade Ib) has been detected in all affected countries except South Africa, which is causing concern due to its potential for wider transmission across age groups, particularly young children.

ALSO READ:  S. Korean Prez vows to expand systemic support for mental health services

Burundi has so far confirmed more than 170 mpox cases in 26 out of the 49 districts in the country, Unicef said.

It noted that children and adolescents aged below 20 years constitute nearly 60 per cent of cases detected, with children under five years old comprising 21 per cent of cases.

Kenya, Burundi, and Uganda have been struggling with multiple emergencies, including drought and floods, in addition to the immediate concerns posed by the virus, Unicef said.

The UN agency also warned concerns remain over the secondary impact of mpox outbreaks on children and adolescents, including stigma, discrimination, and disruptions to schooling and learning.

“Drawing from experiences gained during responses to HIV, Covid-19, and Ebola outbreaks, there must be a collective effort to prioritise plans for supporting survivors, combating stigma, and facilitating continuity of basic social services, especially learning and children’s reintegration into school and community,” Unicef said.

–IANS

int/jk/khz

ALSO READ:  CSIR's project to map cardio-metabolic diseases in India completes 1st phase

Continue Reading

Health/medicine

Ozempic and the uncomfortable truth

Published

on

By

Ozempic and the uncomfortable truth

Ozempic and the uncomfortable truth

New Delhi, Aug 22 (IANS) Ozempic, the diet pill that took the world by storm has been under the public scanner for long, is found to be more devastating than what was originally speculated.

A study conducted at St. Vincent’s University Hospital (SVUH) in Dublin has challenged the prevailing belief that weight loss medications like Ozempic, Wegovy, or Monjaro primarily work by promoting satiety and reducing food intake.

The randomised controlled trial, led by Professor Donal O’Shea of SVUH and the UCD School of Medicine, involved 30 patients and focused on medications based on the hormone Glucagon-like peptide-1 (GLP-1).

The findings, published today in the Journal of the Obesity Society, reveal a strong relationship between increased metabolic activity caused by daily GLP-1 treatment and the amount of weight lost.

Interestingly, individuals with lower metabolic activity before beginning treatment experienced the most significant benefits.

“This study challenges the main narrative about these newer treatments, which is that they simply make you eat less and that any action on energy burn is minimal,” said O’Shea.

ALSO READ:  Know why human cases of H5N1 in US & Australia are cause of concern

“The strength of the association is surprising given the relatively small number of participants, suggesting that this increase in metabolic activity is a significant contributor to how these drugs work.”

O’Shea emphasised the importance of understanding the full mechanism behind these treatments.

“Safe medical treatment for obesity is still in its infancy, and we need to fully understand how the treatment works. Understanding how these agents increase energy burn should be an important part of future research. The diet industry has been long criticised for the bilge and inhumanity it churns out in the name of making people slimmer, with the people in the public eye being the highest targets for it, actors, models etc, some of them being candid about their struggles to maintain the size zero figure. Studies like these throw a light on the uncomfortable part of pop culture.”

–IANS

ts/khz

Continue Reading

Health/medicine

Kolkata hospital horror: SC asks WB Police to not disrupt peaceful protests, CBI probe to continue

Published

on

By

Kolkata hospital horror: SC asks WB Police to not disrupt peaceful protests, CBI probe to continue

Kolkata hospital horror: SC asks WB Police to not disrupt peaceful protests, CBI probe to continue

New Delhi, Aug 22 (IANS) The Supreme Court on Thursday asked the West Bengal Police not to disrupt the peaceful protests in the wake of the horrific incident at Kolkata’s R.G. Kar Medical College and Hospital, where a trainee doctor was raped and murdered earlier this month.

“We categorically reaffirm that peaceful protests shall not be disturbed and disrupted. The state shall not take any action against those who are peacefully protesting against the incident at state-run RG Kar Medical College and Hospital,” a bench presided over by CJI D.Y. Chandrachud said.

The Bench, also comprising Justices J.B. Pardiwala and Manoj Misra, told senior advocate Kapil Sibal, representing the West Bengal government, that the apex court has not injuncted the state police from exercising such lawful powers as entrusted in terms of law, clarifying that the protestors should also comply with the requirements of the law.

“Let the investigation continue,” it remarked, taking on record the status report filed by the Central Bureau of Investigation (CBI) as well by the Kolkata Police in relation to the vandalisation of the hospital premises on the night of August 14.

ALSO READ:  South Korea vows stern response to illegal acts ahead of doctors' collective action

The Supreme Court also asked the jurisdictional court to decide, by 5 p.m. on Friday, the application of the investigative agency seeking permission for a polygraph test of the accused.

Further, it asked the National Task Force (NTF), set up by the government on its direction, to give a hearing to diverse medical associations while formulating effective recommendations relating to the safety, working conditions and well-being of doctors and medical professionals.

“To facilitate filing of suggestions before the NTF, we direct the Secretary in the Union Ministry of Health and Family Welfare to open a specific portal on the website of the ministry on which associations and different stakeholders may submit their suggestions for consideration before the committee,” the SC ordered.

Urging medical professionals across the country to return to work, the apex court assured the resident doctors and interns that no adverse action would be taken against them for participating in protests.

During the hearing, the CJI-led Bench observed: “Ask them (doctors) first to return to work. Once they return to work, nobody is going to take adverse action against the doctors. Let them first come back to work and then, if there is any difficulty, we will make sure that no adverse action is taken against the doctors.”

ALSO READ:  S. Korean Prez vows to expand systemic support for mental health services

It added that “the poor people coming to hospital cannot be left behind in the lurch” and raised concerns about how public health infrastructure would run if doctors did not resume work.

The SC reiterated: “Let all doctors resume work. Please rest assured that once the doctors resume duty, then we will prevail upon the authorities to not take any adverse action.”

Asking all the state governments to address the safety concerns of doctors and medical professionals, the apex court directed the Union Ministry of Health & Family Welfare to convene a meeting with all the Chief Secretaries and Director Generals of Police within a period of one week.

–IANS

pds/vd

Continue Reading

Health/medicine

University doctors probe eye changes in Polaris Dawn mission

Published

on

By

University doctors probe eye changes in Polaris Dawn mission

University doctors probe eye changes in Polaris Dawn mission

New Delhi, Aug 22 (IANS) In order to better understand the changes that astronauts’ eyes undergo during spaceflights, doctors at Augusta University’s Medical College of Georgia (MCG) are working with Polaris Dawn, the first of three human spaceflight missions under the Polaris Program.

More than 70 per cent of astronauts experience these alterations, which are a component of a syndrome known as Spaceflight Associated Neuro-Ocular Syndrome (SANS), according to NASA.

SANS can cause a variety of symptoms, ranging from severe vision loss to the requirement for glasses.

In addition to advancing human spaceflight capabilities, the Polaris Program seeks to raise money and awareness for significant Earthly issues.

As a result of changes in bodily fluids like cerebrospinal fluid (CSF), which can result in structural alterations in the brain, astronauts may suffer changes in their vision as early as their first day in space, according to Dr. Matt Lyon, Director of the MCG Center for Telehealth.

ALSO READ:  Healthcare industry, individuals must focus on 'prevention first': Dr Devi Shetty

While CSF floats upward in space and presses against the optic nerve and retina, gravity on Earth aids in its removal from the optic nerve sheath.

By using portable handheld ultrasound scanners, Lyon’s team hopes to identify the astronauts who are most vulnerable to SANS and comprehend the mechanisms underlying these alterations.

A technology first developed to explore the effects of high cranial pressure and mild traumatic brain injuries (TBIs), MCG has trademarked the idea of utilising portable ultrasound to visualise damage from pressure and fluid changes in the optic nerve sheath.

A $350,000 NIH funding enabled the researchers to work with URSUS Medical Designs LLC to build a 3-D ultrasound device.

Currently, astronauts are being screened with this technology to check for optic nerve sheath damage or incompetence, which Lyon believes could predispose them to SANS.

The crew of Polaris Dawn is being trained by the research team to utilise these ultrasonic instruments to assess fluid and pressure in real time while in orbit.

ALSO READ:  South Korea vows stern response to illegal acts ahead of doctors' collective action

Determining whether the changes in vision are due to pressure, fluid volume, or both will aid in the development of countermeasures.

Using a lower-body negative pressure device, which draws bodily fluids downward, could be one way to mitigate the danger of SANS during space flights.

–IANS

ts/rad

Continue Reading

Health/medicine

Number of COVID-19 patients in S Korea shows signs of abating

Published

on

By

Number of COVID-19 patients in S Korea shows signs of abating

Number of COVID-19 patients in S Korea shows signs of abating

Seoul, Aug 22 (IANS) The number of patients hospitalised for COVID-19 showed signs of abating, health authorities said on Thursday.

Although the weekly number of COVID-19 inpatients grew last week, the growth rate of hospitalisation plunged, according to the Korea Disease Control and Prevention Agency (KDCA), Yonhap news agency reported.

The number of COVID-19 patients in 220 hospitals last week came to 1,444, up 5.7 per cent from a week earlier, the KDCA said.

That compared with 1,366 patients in the second week of this month, up 55.2 per cent from a week earlier, and 880 patients in the first week, up 85.7 per cent from a week ago.

“Considering the current trend, the number of infections is expected to decrease after this week or the next,” KDCA Commissioner Jee Young-mee said during a meeting with related government agencies.

Jee added that the number of infections this week, previously estimated at 350,000, would likely be “smaller than anticipated.”

ALSO READ:  Know why human cases of H5N1 in US & Australia are cause of concern

The KDCA also announced that it has completed the purchase of 260,000 doses of COVID-19 treatments using a reserve fund of 326.8 billion won (US$244.8 million), with 177,000 doses set to be available at local pharmacies starting Monday next week.

To prevent the spread of the virus among students, the government has issued guidelines to schools ahead of the new semester, including requiring students to take leave if they exhibit severe COVID-19 symptoms, for the last COVID-19 pandemic had rattled the strongest of economies and health care systems, leaving a devastating image in its wake, something that not even the two World Wars could match.

South Korea remains vigilant and in good spirits but it can always look back and realise that it can never be too vigilant.

–IANS

ts/dan

Continue Reading

Trending